Antecedent medication use and volume of ischemic stroke: a clinical and neuroimaging evaluation
Stroke is the second most common cause of mortality in the world, and is the leading cause of disability in the United States. It is unclear whether cerebral infarct size is influenced by antecedent medication use in humans. The goal of this study was to investigate the possible influences of prior...
Main Author: | Shideler, Kelsey Idina |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/15088 |
Similar Items
-
Clinical and neuroimaging features of acute ischemic stroke presented with vertigo
by: Xiao-lan YANG, et al.
Published: (2019-01-01) -
Machine Learning in Acute Ischemic Stroke Neuroimaging
by: Haris Kamal, et al.
Published: (2018-11-01) -
Opportunities in multimodal neuroimaging for optimizing thrombolytic therapy for ischemic stroke
by: M. M. Odinak, et al.
Published: (2016-03-01) -
Symptomatic Neonatal Arterial Ischemic Stroke With Prenatal and Postnatal Neuroimaging
by: Mati Pulver MD, et al.
Published: (2017-09-01) -
The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995–2015
by: Xiaoling Chen, et al.
Published: (2016-10-01)